📰 已获 36氪 正式报道Featured on 36Kr  →
AUC 0.839 · 算法备案中 · 交互演示AUC 0.839 · Algorithm Filing in Progress · Live Demo

预防医疗的决策基础设施

The Decision Infrastructure for Preventive Medicine

将健康行为转化为可结算的医疗证据。预测 → 干预 → 归因 → 结算,跑通预防医疗完整闭环。Turning health behaviors into billable medical evidence. Predict → Intervene → Attribute → Settle.

01
预测Predict
风险轨迹建模Risk Trajectory
02
干预Intervene
个性化方案Personalized Plan
03
归因Attribute
PSM因果分析PSM Causal
04
结算Settle
因果证据报告Evidence Report
0.839
模型 AUC · ReHealth CoreModel AUC · ReHealth Core
16
临床特征维度Clinical Features
PSM
因果归因核心方法Causal Attribution Method
我们解决的问题The Problem We Solve
发现太晚Too Late to Act
传统体检一年一次,心血管事件往往在"正常"体检后数月内发生Annual check-ups miss the window — cardiac events often occur months after a "normal" exam
无法量化No Measurable Proof
预防干预效果难以量化,保险公司和医院无法形成可结算的医疗证据Intervention outcomes can't be quantified — insurers and hospitals lack billable preventive evidence
数据孤岛Data Silos
医院、保险、企业数据割裂,无法形成完整的患者健康管理闭环Hospital, insurer, and employer data remain fragmented — no complete health management loop
ReHealth 如何解决How ReHealth Solves It
01
多维风险预测Multi-dim Risk Prediction
16个临床特征,AUC 0.839,实时输出心血管风险信号16 clinical features, AUC 0.839, real-time cardiovascular risk signals
02
个性化干预方案Personalized Intervention
基于风险因子自动生成针对性干预建议,实时推送至患者终端Auto-generate targeted interventions based on risk factors, pushed to patient devices
03
PSM因果归因PSM Causal Attribution
倾向评分匹配消除混杂因素,量化干预真实因果效应PSM eliminates confounders, quantifies true causal effect
04
结算证据生成Settlement Evidence
生成标准化可结算证据报告,向保险公司和医疗机构提交Generate standardized billable evidence reports for insurers and hospitals
四端核心价值Value by Client Type
🏥 医院🏥 Hospital
  • 提前1-3年预测心脑血管风险,识别高危患者Predict cardiovascular risk 1-3 years ahead
  • 辅助医生在疾病发生前主动介入Enable physicians to intervene before disease onset
  • HIS无缝对接,风险信号实时推送至医生工作站Seamless HIS integration, real-time risk signals
  • 产出因果归因证据,向支付方证明干预真实价值Generate causal evidence to prove intervention value
🛡️ 保险公司🛡️ Insurance
  • 预测高赔付人群,在赔付窗口关闭前锁定干预机会Predict high-claim populations before payout window closes
  • PSM因果证据量化干预降低赔付的真实效果PSM causal evidence quantifies real impact on claims
  • 将预防结果转化为标准化可结算证据Convert prevention outcomes into billable evidence
  • 支持险企从赔付方转型为主动健康管理者Help insurers shift to proactive health managers
🏢 企业🏢 Enterprise
  • 员工群体心脑血管风险预测与分层Cardiovascular risk prediction across workforce
  • 量化干预ROI,将健康投入与医疗费用降低强绑定Quantify intervention ROI linked to cost reduction
  • 因果证据报告支持企业向保险方申请费率优惠Causal evidence supports premium negotiation
  • API订阅按需接入,无需自建健康数据团队API subscription, no in-house health data team needed
💊 药企💊 Pharma
  • 开放真实世界患者数据授权,支持靶点发现与患者分层License real-world data for target discovery
  • 带干预轨迹的动态数据集,价值远超静态历史数据Dynamic datasets with intervention trajectories
  • PSM因果分析可直接复用于临床试验设计优化PSM analysis applicable to clinical trial design
  • 产出符合NMPA要求的真实世界证据NMPA-compliant RWE for drug registration
为什么不是传统方案Why Not Traditional Approaches
传统体检/人工评估Traditional Check-up
ReHealth Core
评估频率Assessment Frequency
每年1次Once a year
实时连续Real-time continuous
干预效果量化Intervention Quantification
无法量化Not quantifiable
PSM因果证据PSM causal evidence
结算可行性Settlement Feasibility
无标准化证据No standardized evidence
可结算证据报告Billable evidence report
多端数据整合Multi-source Integration
数据孤岛Data silos
HIS/医保/穿戴设备HIS / Claims / Wearables
个性化程度Personalization
通用建议Generic advice
16维特征个性化16-dim personalized plan
🔬 心脑血管风险预测 · 输入患者基础指标Cardiovascular Risk Prediction · Enter Patient Data
模型计算中…Computing…
💊 个性化干预方案生成Personalized Intervention Plan

基于患者风险因子,自动生成针对性干预建议。请先完成风险预测,或直接点击生成示例方案。Auto-generates targeted interventions based on patient risk factors. Run prediction first or click to generate example plan.

⚖️ PSM 因果归因分析PSM Causal Attribution Analysis
📋 结算证据报告Settlement Evidence Report

基于PSM因果分析结果,生成可提交给保险公司和医疗机构的标准化结算证据报告。Generate standardized settlement evidence reports for insurers and healthcare institutions based on PSM causal analysis.

📊 批量风险筛查 · 上传患者CSVBatch Risk Screening · Upload CSV
📁
上传患者数据 CSV 文件Upload Patient CSV File
支持中英文列名,最多500人,编码 UTF-8Supports CN/EN headers, up to 500 patients, UTF-8
CSV 列名格式(顺序不限)CSV Column Format (any order)
id, age, sex, bmi, systolic_bp, diastolic_bp, fasting_glucose,
total_cholesterol, ldl, hdl, triglycerides, exercise_days,
smoking, drinking, family_history, diabetes, hypertension
sex: 1=男/Male 0=女/Female  |  是/Yes=1 否/No=0
批量计算中…Computing…
🏥 医院 HIS 接入演示 · 医生工作站实时风险评分Hospital HIS Integration · Real-time Risk at Workstation
API 在线Online
HIS 推送患者数据HIS Patient Push
等待推送…Waiting for push…
系统日志System Log
[系统] ReHealth Core API 就绪,等待 HIS 推送…[System] ReHealth Core API ready, awaiting HIS push…
今日推送队列Today's Push Queue
暂无记录No records yet
3.3亿330M
中国心血管病患者总数Cardiovascular Patients in China
据《中国心血管健康与疾病报告 2023》,我国现有心血管病患者约 3.3 亿,心血管疾病死亡占城乡居民总死亡原因首位。预防窗口的缺失,是这一数字持续攀升的核心原因。 According to the China Cardiovascular Health and Disease Report 2023, approximately 330 million people in China have cardiovascular disease — the leading cause of death nationally. The absence of a prevention window is the core driver of this rising toll.
核心概念定义Core Concept Definitions
DEFINITION 01

可结算证据Billable Prevention Evidence

指通过科学方法量化的、可被医疗支付体系(医保、商业保险、企业雇主)正式认可并用于费用结算的预防干预效果证明。不同于传统医疗记录,可结算证据须包含因果归因链路——即证明干预与健康结果改善之间存在统计意义上的因果关系,而非单纯相关性。ReHealth Core 通过 PSM 倾向评分匹配生成符合真实世界证据(RWE)标准的因果报告,作为向支付方提交的结算依据。 Quantified proof of preventive intervention outcomes, formally recognized by healthcare payers (public insurance, commercial insurers, employers) for reimbursement. Unlike traditional medical records, billable evidence requires a causal attribution chain — proving the intervention caused health improvement, not mere correlation. ReHealth Core generates RWE-standard causal reports via PSM for submission to payers.

DEFINITION 02

PSM 因果归因Propensity Score Matching

倾向评分匹配(PSM)是准实验因果推断的核心方法,通过对干预组和对照组在年龄、性别、基线风险等混杂变量上的统计匹配,消除选择偏倚,从而将干预效果从噪声中剥离出来。这一方法论已在 Lancet、NEJM 等顶级期刊被广泛采用,是真实世界证据(RWE)生成的标准路径之一。 PSM is the core quasi-experimental method for causal inference. By statistically matching treatment and control groups on confounders (age, sex, baseline risk), it eliminates selection bias and isolates the true intervention effect. Widely adopted in Lancet and NEJM, it is a standard pathway for Real-World Evidence generation.

DEFINITION 03

真实世界证据Real-World Evidence (RWE)

区别于随机对照试验(RCT),真实世界证据来源于常规诊疗、健康管理、可穿戴设备等真实医疗场景中积累的数据。国家药监局(NMPA)、美国 FDA 均已发布 RWE 指南,ReHealth Core 的因果证据报告可直接用于医保谈判、险企费率优化和药企注册申报。 Unlike RCTs, Real-World Evidence derives from routine clinical care, health management programs, and wearables. Both NMPA and FDA have issued RWE guidelines. ReHealth Core's causal reports are directly applicable to insurance negotiations, premium optimization, and drug regulatory submissions.

DEFINITION 04

医疗级联邦学习Medical-Grade Federated Learning

联邦学习允许多方机构在不共享原始数据的前提下协同训练模型——患者数据始终留存于医院本地,仅上传经过差分隐私处理的模型梯度。从根本上解决医疗数据"能用不能看、能算不能拿"的合规困境,满足《个人信息保护法》与《数据安全法》的严格要求。 Federated learning allows multi-party institutions to collaboratively train models without sharing raw data — patient data stays on-premise, only differentially-private model gradients are uploaded. This solves the core healthcare data compliance dilemma, meeting PIPL and Data Security Law requirements.

DEFINITION 05

预防结算Prevention Settlement

将预防医疗干预产生的健康改善效果,通过标准化因果证据转化为可被医疗支付体系正式结算的收益项。ReHealth Core 以"预防结算"为核心目标函数,打通从风险预测到干预归因再到支付方认可的完整商业闭环,推动预防医疗从成本中心转变为收益中心。 Converting health improvements from preventive interventions into formally reimbursable items via standardized causal evidence. ReHealth Core uses prevention settlement as its core objective function — closing the full loop from risk prediction to causal attribution to payer recognition, transforming prevention from a cost center to a revenue center.

DEFINITION 06

AUC 0.839 的含义What AUC 0.839 Means

AUC(受试者操作特征曲线下面积)是分类模型区分能力的标准度量,范围 0.5(随机猜测)到 1.0(完美区分)。AUC 0.839 意味着:从任意一对高低风险患者中,模型有 83.9% 的概率正确识别出谁的风险更高。在真实世界临床场景中,AUC > 0.8 通常被认为具有良好的临床实用价值。 AUC (Area Under the ROC Curve) measures a model's discriminative ability, ranging from 0.5 (random) to 1.0 (perfect). AUC 0.839 means the model correctly identifies the higher-risk patient in 83.9% of random pairs. In real-world clinical settings, AUC > 0.8 is considered to have strong practical utility.

技术架构摘要Technical Architecture Summary
预测层 · PredictionPrediction Layer

采用 CatBoost 梯度提升树,输入 16 个临床特征维度(含血压、血脂、血糖、BMI、生活行为习惯、家族史等),输出连续心血管风险评分与 SHAP 特征重要性分析,支持实时推理(<200ms 响应)。 CatBoost gradient boosting with 16 clinical features (BP, lipids, glucose, BMI, lifestyle, family history), outputting continuous cardiovascular risk scores and SHAP feature importance. Real-time inference (<200ms response).

归因层 · AttributionAttribution Layer

基于倾向评分匹配(PSM)的因果推断引擎,支持综合干预、药物干预、生活方式干预和数字健康干预四类场景,输出标准化 ATT(平均处理效应)及置信区间,符合真实世界证据(RWE)方法论要求。 PSM-based causal inference engine supporting four intervention types: comprehensive, medication, lifestyle, and digital health. Outputs standardized ATT (Average Treatment Effect) with confidence intervals, compliant with RWE methodology.

数据安全层 · SecuritySecurity Layer

医疗级联邦学习架构,患者原始数据不出域,差分隐私保护聚合梯度,端到端加密传输。满足《个人信息保护法》《数据安全法》《网络安全法》三法合规,医疗器械软件注册备案中。 Medical-grade federated learning: raw patient data stays on-premise, differentially-private gradient aggregation, end-to-end encrypted transmission. Compliant with PIPL, Data Security Law, and Cybersecurity Law. Medical device software registration in progress.

接入层 · IntegrationIntegration Layer

标准 RESTful API,提供 HIS 医院信息系统对接、保险核保系统接入、企业 HR 健康平台集成三条预置通路。支持 JSON/CSV 数据格式,平均接入周期 < 2 周,按调用量订阅计费。 Standard RESTful API with three pre-built integration paths: hospital HIS, insurance underwriting systems, and enterprise HR health platforms. JSON/CSV support, average integration time <2 weeks, usage-based subscription pricing.

常见问题FAQ
ReHealth Core 的预测准确率是多少?How accurate is ReHealth Core's risk prediction?
基于 16 个临床特征维度,心脑血管风险预测模型 AUC 达到 0.839,可提前 1-3 年识别高危患者。AUC 0.839 using 16 clinical features, enabling cardiovascular risk identification 1-3 years before disease onset.
如何证明预防干预的有效性?How is intervention effectiveness proven?
采用 PSM 倾向评分匹配因果归因,消除混杂因素,量化干预真实效应,生成可提交给保险公司和医疗机构的标准化结算证据报告。PSM (Propensity Score Matching) eliminates confounders to quantify true causal effects, generating standardized settlement evidence reports for insurers and hospitals.
ReHealth Core 与其他健康AI平台有何不同?What makes ReHealth Core different from other health AI platforms?
竞品止步于"预测",ReHealth Core 是唯一跑通预测→干预→归因→结算完整闭环的平台,将预防结果转化为可结算的因果证据。Competitors stop at prediction. ReHealth Core is the only platform completing the full loop: Predict → Intervene → Attribute → Settle, converting prevention outcomes into billable causal evidence.
患者数据如何保障安全?How is patient data security ensured?
医疗级联邦学习架构,患者原始数据始终留在机构本地,仅上传脱敏聚合信号,满足《个人信息保护法》《数据安全法》合规要求。Medical-grade federated learning: raw patient data never leaves the institution. Only de-identified aggregate signals are uploaded, compliant with PIPL and Data Security Law.

什么是预防医疗的"可结算证据"?What is "Billable Prevention Evidence"?

可结算证据是指通过科学方法(主要是 PSM 因果推断)量化干预效果后,生成的可被医保、商业保险或企业雇主正式认可并用于费用报销的标准化报告。核心在于"因果性"而非"相关性"——必须证明是干预本身导致了健康结果改善。这是 ReHealth Core 的根本创新:不仅预测风险,更为预防行为创造可被支付体系认可的经济价值。Billable prevention evidence is a standardized report generated after quantifying intervention outcomes via PSM causal inference, formally recognized by public insurance, commercial insurers, or employers for reimbursement. The key is causality, not correlation — proving the intervention itself caused health improvement.

PSM 因果归因具体如何工作?How Does PSM Causal Attribution Work?

PSM 分三步:① 对每位患者计算"倾向评分"——在其年龄、性别、基线风险等特征下接受干预的概率;② 将干预组与对照组中倾向评分相近的患者配对,形成统计上可比的两组;③ 比较配对后两组的健康结果差异,得出平均处理效应(ATT)及置信区间。这一方法消除了"健康人更倾向参与健康管理"的选择偏倚,使归因结论具有因果解释力。PSM works in three steps: ① calculate a propensity score for each patient; ② match treated and control patients with similar scores; ③ compare outcomes to derive the Average Treatment Effect (ATT) with confidence intervals — eliminating selection bias.

联邦学习如何保障患者数据不出院?How Does Federated Learning Keep Patient Data On-Premise?

在联邦学习架构下,模型训练分布在各机构本地服务器,患者原始数据全程不离开机构本地环境。只有经过差分隐私处理的模型梯度会被加密上传至聚合节点。即使节点遭受攻击,攻击者也无法从梯度中还原出任何个人患者信息。架构符合《个人信息保护法》第 23 条数据最小化原则。Under federated learning, model training runs on each institution's local servers — raw patient data never leaves. Only differentially-private model gradients are encrypted and uploaded. Even if the aggregation node is compromised, no individual patient data can be reconstructed.

⚠️ 本平台为面向医疗机构、保险机构等B端专业用户的健康风险评估辅助工具,输出结果仅供专业人员参考,不构成医学诊断或治疗建议,不替代执业医师的临床判断。软件医疗器械注册备案中。 This platform is a health risk assessment tool for professional B2B users (healthcare & insurance institutions). Outputs are for professional reference only and do not constitute medical diagnosis or treatment advice, nor replace clinical judgment by licensed physicians. Medical device software registration in progress.